<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 1]
- [q-bio.QM](#q-bio.QM) [Total: 2]
- [eess.IV](#eess.IV) [Total: 1]
- [stat.AP](#stat.AP) [Total: 1]
- [cs.LG](#cs.LG) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [Detecting Batch Heterogeneity via Likelihood Clustering](https://arxiv.org/abs/2601.09758)
*Austin Talbot,Yue Ke*

Main category: q-bio.GN

TL;DR: 提出基于贝叶斯模型证据的批次效应检测方法，通过证据空间中的混合结构似然比检验，区分技术变异与生物信号，在临床基因组诊断中优于传统方法。


<details>
  <summary>Details</summary>
Motivation: 批次效应是基因组诊断中的主要混杂因素。现有方法要么基于原始特征聚类样本（可能混淆生物信号与技术变异），要么需要已知的批次标签（通常不可得）。需要一种能区分技术变异与生物变异的方法。

Method: 基于贝叶斯模型证据聚类样本。核心洞察：证据量化数据与模型假设的兼容性，技术伪影违反假设降低证据，而生物变异（包括CNV状态）被模型预期产生高证据。这种不对称性提供了区分批次效应与生物学的判别信号。将异质性检测形式化为证据空间中混合结构的似然比检验，使用参数自举校准确保保守的假阳性率。

Result: 在合成数据上验证了正确的I型错误控制；在三个临床靶向测序panel（液体活检、BRCA、地中海贫血）上展示了不同批次效应机制；在小鼠电生理记录上证明了跨模态泛化能力。相比标准基于相关性和降维的方法，实现了更优的聚类准确性，同时保持了临床使用所需的保守性。

Conclusion: 该方法通过贝叶斯模型证据有效区分技术批次效应与生物变异，为临床基因组诊断提供了可靠的批次效应检测工具，优于现有方法且具有跨模态适用性。

Abstract: Batch effects represent a major confounder in genomic diagnostics. In copy number variant (CNV) detection from NGS, many algorithms compare read depth between test samples and a reference sample, assuming they are process-matched. When this assumption is violated, with causes ranging from reagent lot changes to multi-site processing, the reference becomes inappropriate, introducing false CNV calls or masking true pathogenic variants. Detecting such heterogeneity before downstream analysis is critical for reliable clinical interpretation. Existing batch effect detection methods either cluster samples based on raw features, risking conflation of biological signal with technical variation, or require known batch labels that are frequently unavailable. We introduce a method that addresses both limitations by clustering samples according to their Bayesian model evidence. The central insight is that evidence quantifies compatibility between data and model assumptions, technical artifacts violate assumptions and reduce evidence, whereas biological variation, including CNV status, is anticipated by the model and yields high evidence. This asymmetry provides a discriminative signal that separates batch effects from biology. We formalize heterogeneity detection as a likelihood ratio test for mixture structure in evidence space, using parametric bootstrap calibration to ensure conservative false positive rates. We validate our approach on synthetic data demonstrating proper Type I error control, three clinical targeted sequencing panels (liquid biopsy, BRCA, and thalassemia) exhibiting distinct batch effect mechanisms, and mouse electrophysiology recordings demonstrating cross-modality generalization. Our method achieves superior clustering accuracy compared to standard correlation-based and dimensionality-reduction approaches while maintaining the conservativeness required for clinical usage.

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [2] [Robust and Generalizable Atrial Fibrillation Detection from ECG Using Time-Frequency Fusion and Supervised Contrastive Learning](https://arxiv.org/abs/2601.10202)
*Hongtao Li,Jia Wei,Jia Xiao,Yuanjun Lai,Mingyang Liu,Shuzhen Lv,Xueqiang Ouyang*

Main category: q-bio.QM

TL;DR: 提出跨模态深度学习框架，结合双向门控模块和跨模态监督对比学习，提升房颤检测的鲁棒性和跨数据集泛化能力


<details>
  <summary>Details</summary>
Motivation: 房颤是常见心律失常，增加中风和心衰风险，需要可靠的心电图检测方法。现有深度学习方法难以有效利用时频互补信息，在数据集内鲁棒性和跨数据集泛化方面存在局限

Method: 提出跨模态深度学习框架：1) 双向门控模块(BGM)实现时域和频域特征的动态相互精炼；2) 跨模态监督对比学习(CSCL)策略，在联合嵌入空间中拉近同类样本、推远不同类样本

Result: 在AFDB和CPSC2021数据集上进行五折交叉验证和双向跨数据集实验，在多个指标上优于现有方法，实现高数据集内鲁棒性和优秀的跨数据集泛化能力，同时计算效率高、抗干扰能力强

Conclusion: 提出的跨模态框架有效解决了房颤检测中的时频信息互补利用问题，显著提升了模型鲁棒性和泛化能力，适合边缘部署应用

Abstract: Atrial fibrillation (AF) is a common cardiac arrhythmia that significantly increases the risk of stroke and heart failure, necessitating reliable and generalizable detection methods from electrocardiogram (ECG) recordings. Although deep learning has advanced automated AF diagnosis, existing approaches often struggle to exploit complementary time-frequency information effectively, limiting both robustness under intra-dataset and generalization across diverse clinical datasets. To address these challenges, we propose a cross-modal deep learning framework comprising two key components: a Bidirectional Gating Module (BGM) and a Cross-modal Supervised Contrastive Learning (CSCL) strategy. The BGM facilitates dynamic, reciprocal refinement between time and frequency domain features, enhancing model robustness to signal variations within a dataset. Meanwhile, CSCL explicitly structures the joint embedding space by pulling together label-consistent samples and pushing apart different ones, thereby improving inter-class separability and enabling strong cross-dataset generalization. We evaluate our method through five-fold cross-validation on the AFDB and the CPSC2021 dataset, as well as bidirectional cross-dataset experiments (training on one and testing on the other). Results show consistent improvements over state-of-the-art methods across multiple metrics, demonstrating that our approach achieves both high intra-dataset robustness and excellent cross-dataset generalization. We further demonstrate that our method achieves high computational efficiency and anti-interference capability, making it suitable for edge deployment.

</details>


### [3] [A Predictive Model for Synergistic Oncolytic Virotherapy: Unveiling the Ping-Pong Mechanism and Optimal Timing of Combined Vesicular Stomatitis and Vaccinia Viruses](https://arxiv.org/abs/2601.10405)
*Joseph Malinzi,Amina Eladdadi,Rachid Ouifki,Raluca Eftimie,Anotida Madzvamuse,Helen M. Byrne*

Main category: q-bio.QM

TL;DR: 该研究提出了一个数学模型，描述VSV和VV病毒联合治疗的协同机制，通过"乒乓"协同作用增强抗肿瘤效果，其中VV感染细胞产生的B18R蛋白中和干扰素-α，促进VSV在肿瘤中的复制。


<details>
  <summary>Details</summary>
Motivation: 研究旨在理解VSV和VV病毒联合治疗肿瘤的协同机制，解决溶瘤病毒治疗(OVT)中的时机和剂量挑战，通过数学模型揭示两种病毒如何相互作用以增强抗肿瘤效果。

Method: 建立数学模型描述肿瘤细胞、病毒复制和干扰素介导的免疫反应之间的动态相互作用，进行数值模拟、分岔分析和敏感性分析，识别关键参数阈值，并进行时间优化以确定最佳给药策略。

Result: 联合治疗在约50天内实现完全肿瘤清除，比VV单药治疗(56天)加速11%，而VSV单药无法根除肿瘤。分岔分析确定了病毒爆发规模和B18R抑制的关键阈值，敏感性分析显示感染率和爆发规模对疗效影响最大。时间优化表明，立即给予VSV后延迟1-19天给予VV可获得最佳治疗效果。

Conclusion: VSV和VV联合治疗通过"乒乓"协同机制显著增强抗肿瘤效果，其中VV产生的B18R蛋白中和干扰素-α，促进VSV复制。数学模型为优化溶瘤病毒治疗的时机和剂量提供了策略指导，有助于克服OVT的临床挑战。

Abstract: We present a mathematical model that describes the synergistic mechanism of combined Vesicular Stomatitis Virus (VSV) and Vaccinia Virus (VV). The model captures the dynamic interplay between tumor cells, viral replication, and the interferon-mediated immune response, revealing a `ping-pong' synergy where VV-infected cells produce B18R protein that neutralizes interferon-$α$, thereby enhancing VSV replication within the tumor. Numerical simulations demonstrate that this combination achieves complete tumor clearance in approximately 50 days, representing an 11\% acceleration compared to VV monotherapy (56 days), while VSV alone fails to eradicate tumors. Through bifurcation analysis, we identify critical thresholds for viral burst size and B18R inhibition, while sensitivity analysis highlights infection rates and burst sizes as the most influential parameters for treatment efficacy. Temporal optimization reveals that therapeutic outcomes are maximized through immediate VSV administration followed by delayed VV injection within a 1-19 day window, offering a strategic approach to overcome the timing and dosing challenges inherent in OVT.

</details>


<div id='eess.IV'></div>

# eess.IV [[Back]](#toc)

### [4] [Cell Behavior Video Classification Challenge, a benchmark for computer vision methods in time-lapse microscopy](https://arxiv.org/abs/2601.10250)
*Raffaella Fiamma Cabini,Deborah Barkauskas,Guangyu Chen,Zhi-Qi Cheng,David E Cicchetti,Judith Drazba,Rodrigo Fernandez-Gonzalez,Raymond Hawkins,Yujia Hu,Jyoti Kini,Charles LeWarne,Xufeng Lin,Sai Preethi Nakkina,John W Peterson,Koert Schreurs,Ayushi Singh,Kumaran Bala Kandan Viswanathan,Inge MN Wortel,Sanjian Zhang,Rolf Krause,Santiago Fernandez Gonzalez,Diego Ulisse Pizzagalli*

Main category: eess.IV

TL;DR: 该论文组织了细胞行为视频分类挑战赛(CBVCC)，评估了35种方法在复杂细胞行为视频分类任务上的表现，比较了基于跟踪特征、端到端深度学习以及特征融合三种方法的效果。


<details>
  <summary>Details</summary>
Motivation: 显微镜视频中复杂细胞行为的分类对于理解生物过程动态至关重要，但这是计算机视觉的前沿挑战，需要能够有效建模无刚性边界物体的形状和运动、从整个图像序列提取层次化时空特征、并处理视场中多个对象的方法。

Method: 组织了细胞行为视频分类挑战赛(CBVCC)，评估了35种方法，主要分为三类：1)基于跟踪提取特征的分类方法；2)端到端深度学习架构，直接从整个视频序列学习时空特征而无需显式细胞跟踪；3)将跟踪特征与图像特征融合的集成方法。

Result: 论文讨论了参赛者取得的结果，并比较了每种方法的潜力和局限性。挑战赛为研究细胞动力学的计算机视觉方法发展提供了基准和基础。

Conclusion: 该挑战赛为细胞行为视频分类建立了基准，比较了不同方法的优缺点，为开发用于研究细胞动力学的计算机视觉方法奠定了基础，有助于推动这一前沿领域的发展。

Abstract: The classification of microscopy videos capturing complex cellular behaviors is crucial for understanding and quantifying the dynamics of biological processes over time. However, it remains a frontier in computer vision, requiring approaches that effectively model the shape and motion of objects without rigid boundaries, extract hierarchical spatiotemporal features from entire image sequences rather than static frames, and account for multiple objects within the field of view.
  To this end, we organized the Cell Behavior Video Classification Challenge (CBVCC), benchmarking 35 methods based on three approaches: classification of tracking-derived features, end-to-end deep learning architectures to directly learn spatiotemporal features from the entire video sequence without explicit cell tracking, or ensembling tracking-derived with image-derived features.
  We discuss the results achieved by the participants and compare the potential and limitations of each approach, serving as a basis to foster the development of computer vision methods for studying cellular dynamics.

</details>


<div id='stat.AP'></div>

# stat.AP [[Back]](#toc)

### [5] [MitoFREQ: A Novel Approach for Mitogenome Frequency Estimation from Top-level Haplogroups and Single Nucleotide Variants](https://arxiv.org/abs/2601.10464)
*Mikkel Meyer Andersen,Nicole Huber,Kimberly S Andreaggi,Tóra Oluffa Stenberg Olsen,Walther Parson,Charla Marshall*

Main category: stat.AP

TL;DR: 提出MitoFREQ方法，利用HelixMTdb和gnomAD数据库估算线粒体基因组频率，通过顶级单倍群分类和稀有SNV频率加权，为法医DNA证据提供统计评估。


<details>
  <summary>Details</summary>
Motivation: 高质量线粒体全基因组序列的群体数据有限，限制了法医遗传学中线粒体DNA证据的统计评估。需要一种可靠的方法来估算线粒体基因组的群体频率。

Method: MitoFREQ方法：1) 将给定线粒体基因组分类到30个顶级单倍群中；2) 使用该顶级单倍群中最稀有SNV的频率；3) 用顶级单倍群频率加权。仅需227个特定位置即可完成分类，适用于低质量样本。

Result: 方法在高质量法医参考数据集和GenBank多样化线粒体基因组集合上测试，证明具有鲁棒性。产生的似然比在100-100,000范围内，能显著增强法医mtDNA证据的统计评估能力。

Conclusion: MitoFREQ为线粒体基因组频率估算提供了可靠方法，开发了开源R包mitofreq和Shiny应用，有助于加强法医线粒体DNA证据的统计评估。

Abstract: Lineage marker population frequencies can serve as one way to express evidential value in forensic genetics. However, for high-quality whole mitochondrial DNA genome sequences (mitogenomes), population data remain limited. In this paper, we offer a new method, MitoFREQ, for estimating the population frequencies of mitogenomes. MitoFREQ uses the mitogenome resources HelixMTdb and gnomAD, harbouring information from 195,983 and 56,406 mitogenomes, respectively. Neither HelixMTdb nor gnomAD can be queried directly for individual mitogenome frequencies, but offers single nucleotide variant (SNV) allele frequencies for each of 30 "top-level" haplogroups (TLHG). We propose using the HelixMTdb and gnomAD resources by classifying a given mitogenome within the TLHG scheme and subsequently using the frequency of its rarest SNV within that TLHG weighted by the TLHG frequency. We show that this method is guaranteed to provide a higher population frequency estimate than if a refined haplogroup and its SNV frequencies were used. Further, we show that top-level haplogrouping can be achieved by using only 227 specific positions for 99.9% of the tested mitogenomes, potentially making the method available for low-quality samples. The method was tested on two types of datasets: high-quality forensic reference datasets and a diverse collection of scrutinised mitogenomes from GenBank. This dual evaluation demonstrated that the approach is robust across both curated forensic data and broader population-level sequences. This method produced likelihood ratios in the range of 100-100,000, demonstrating its potential to strengthen the statistical evaluation of forensic mtDNA evidence. We have developed an open-source R package `mitofreq` that implements our method, including a Shiny app where custom TLHG frequencies can be supplied.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [6] [Comparative Evaluation of Deep Learning-Based and WHO-Informed Approaches for Sperm Morphology Assessment](https://arxiv.org/abs/2601.10070)
*Mohammad Abbadi*

Main category: cs.LG

TL;DR: 本研究比较了基于图像的深度学习模型(HuSHeM)与WHO标准结合炎症指数(WHO(+SIRI))在精子形态评估中的表现，发现深度学习模型在预测性能、校准和临床效用方面均优于传统方法。


<details>
  <summary>Details</summary>
Motivation: 精子形态评估是男性生育力评估的关键但主观的组成部分，常受到观察者间变异性和资源限制的影响。需要更客观、可重复的评估方法来提高精子形态质量评估的可靠性。

Method: 提出了一个比较性生物医学人工智能框架，评估基于图像的深度学习模型(HuSHeM)与基于WHO标准结合系统性炎症反应指数(SIRI)的临床基线方法。HuSHeM模型在高分辨率精子形态图像上训练，并在独立临床队列中评估。使用区分度、校准和临床效用分析来评估模型性能。

Result: HuSHeM模型显示出更高的区分性能(更高的AUC值)，在类别不平衡情况下表现更好(更高的PR-AUC值)，校准分析显示预测概率与观察结果更一致，决策曲线分析表明在临床相关阈值概率范围内具有更大的净临床效益。

Conclusion: 基于图像的深度学习相比传统的基于规则和炎症增强的标准，可能提供更好的预测可靠性和临床效用。该框架支持精子形态的客观和可重复评估，可作为生育筛查和转诊工作流程中的决策支持工具，但并非旨在替代临床判断或实验室评估。

Abstract: Assessment of sperm morphological quality remains a critical yet subjective component of male fertility evaluation, often limited by inter-observer variability and resource constraints. This study presents a comparative biomedical artificial intelligence framework evaluating an image-based deep learning model (HuSHeM) alongside a clinically grounded baseline derived from World Health Organization criteria augmented with the Systemic Inflammation Response Index (WHO(+SIRI)).
  The HuSHeM model was trained on high-resolution sperm morphology images and evaluated using an independent clinical cohort. Model performance was assessed using discrimination, calibration, and clinical utility analyses. The HuSHeM model demonstrated higher discriminative performance, as reflected by an increased area under the receiver operating characteristic curve with relatively narrow confidence intervals compared to WHO(+SIRI). Precision-recall analysis further indicated improved performance under class imbalance, with higher precision-recall area values across evaluated thresholds. Calibration analysis indicated closer agreement between predicted probabilities and observed outcomes for HuSHeM, while decision curve analysis suggested greater net clinical benefit across clinically relevant threshold probabilities.
  These findings suggest that image-based deep learning may offer improved predictive reliability and clinical utility compared with traditional rule-based and inflammation-augmented criteria. The proposed framework supports objective and reproducible assessment of sperm morphology and may serve as a decision-support tool within fertility screening and referral workflows. The proposed models are intended as decision-support or referral tools and are not designed to replace clinical judgment or laboratory assessment.

</details>
